Cargando…
A Neurofunctional Domains Approach to Evaluate D1/D5 Dopamine Receptor Partial Agonism on Cognition and Motivation in Healthy Volunteers With Low Working Memory Capacity
BACKGROUND: Dopamine D1 receptor signaling plays key roles in core domains of neural function, including cognition and reward processing; however, many questions remain about the functions of circuits modulated by dopamine D1 receptor, largely because clinically viable, selective agonists have yet t...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251631/ https://www.ncbi.nlm.nih.gov/pubmed/32055822 http://dx.doi.org/10.1093/ijnp/pyaa007 |
_version_ | 1783538994843222016 |
---|---|
author | Balice-Gordon, Rita Honey, Garry D Chatham, Christopher Arce, Estibaliz Duvvuri, Sridhar Naylor, Melissa Graham Liu, Wenlei Xie, Zhiyong DeMartinis, Nicholas Harel, Brian T Braley, Gabriel H Kozak, Rouba Park, Lovingly Gray, David L |
author_facet | Balice-Gordon, Rita Honey, Garry D Chatham, Christopher Arce, Estibaliz Duvvuri, Sridhar Naylor, Melissa Graham Liu, Wenlei Xie, Zhiyong DeMartinis, Nicholas Harel, Brian T Braley, Gabriel H Kozak, Rouba Park, Lovingly Gray, David L |
author_sort | Balice-Gordon, Rita |
collection | PubMed |
description | BACKGROUND: Dopamine D1 receptor signaling plays key roles in core domains of neural function, including cognition and reward processing; however, many questions remain about the functions of circuits modulated by dopamine D1 receptor, largely because clinically viable, selective agonists have yet to be tested in humans. METHODS: Using a novel, exploratory neurofunctional domains study design, we assessed the safety, tolerability, pharmacodynamics, and pharmacokinetics of PF-06412562, a selective D1/D5R partial agonist, in healthy male volunteers who met prespecified criteria for low working memory capacity. Functional magnetic resonance imaging, electrophysiologic endpoints, and behavioral paradigms were used to assess working memory, executive function, and motivation/reward processing following multiple-dose administration of PF-06412562. A total of 77 patients were assigned PF-06412562 (3 mg twice daily and 15 mg twice daily) or placebo administered for 5 to 7 days. Due to the exploratory nature of the study, it was neither powered for any specific treatment effect nor corrected for multiple comparisons. RESULTS: Nominally significant improvements from baseline in cognitive endpoints were observed in all 3 groups; however, improvements in PF-06412562–treated patients were less than in placebo-treated participants. Motivation/reward processing endpoints were variable. PF-06412562 was safe and well tolerated, with no serious adverse events, severe adverse events, or adverse events leading to dose reduction or temporary discontinuation except for 1 permanent discontinuation due to increased orthostatic heart rate. CONCLUSIONS: PF-06412562, in the dose range and patient population explored in this study, did not improve cognitive function or motivation/reward processing more than placebo over the 5- to 7-day treatment period. CLINICALTRIALS.GOV IDENTIFIER: NCT02306876 |
format | Online Article Text |
id | pubmed-7251631 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-72516312020-06-02 A Neurofunctional Domains Approach to Evaluate D1/D5 Dopamine Receptor Partial Agonism on Cognition and Motivation in Healthy Volunteers With Low Working Memory Capacity Balice-Gordon, Rita Honey, Garry D Chatham, Christopher Arce, Estibaliz Duvvuri, Sridhar Naylor, Melissa Graham Liu, Wenlei Xie, Zhiyong DeMartinis, Nicholas Harel, Brian T Braley, Gabriel H Kozak, Rouba Park, Lovingly Gray, David L Int J Neuropsychopharmacol Regular Research Articles BACKGROUND: Dopamine D1 receptor signaling plays key roles in core domains of neural function, including cognition and reward processing; however, many questions remain about the functions of circuits modulated by dopamine D1 receptor, largely because clinically viable, selective agonists have yet to be tested in humans. METHODS: Using a novel, exploratory neurofunctional domains study design, we assessed the safety, tolerability, pharmacodynamics, and pharmacokinetics of PF-06412562, a selective D1/D5R partial agonist, in healthy male volunteers who met prespecified criteria for low working memory capacity. Functional magnetic resonance imaging, electrophysiologic endpoints, and behavioral paradigms were used to assess working memory, executive function, and motivation/reward processing following multiple-dose administration of PF-06412562. A total of 77 patients were assigned PF-06412562 (3 mg twice daily and 15 mg twice daily) or placebo administered for 5 to 7 days. Due to the exploratory nature of the study, it was neither powered for any specific treatment effect nor corrected for multiple comparisons. RESULTS: Nominally significant improvements from baseline in cognitive endpoints were observed in all 3 groups; however, improvements in PF-06412562–treated patients were less than in placebo-treated participants. Motivation/reward processing endpoints were variable. PF-06412562 was safe and well tolerated, with no serious adverse events, severe adverse events, or adverse events leading to dose reduction or temporary discontinuation except for 1 permanent discontinuation due to increased orthostatic heart rate. CONCLUSIONS: PF-06412562, in the dose range and patient population explored in this study, did not improve cognitive function or motivation/reward processing more than placebo over the 5- to 7-day treatment period. CLINICALTRIALS.GOV IDENTIFIER: NCT02306876 Oxford University Press 2020-02-14 /pmc/articles/PMC7251631/ /pubmed/32055822 http://dx.doi.org/10.1093/ijnp/pyaa007 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of CINP. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Regular Research Articles Balice-Gordon, Rita Honey, Garry D Chatham, Christopher Arce, Estibaliz Duvvuri, Sridhar Naylor, Melissa Graham Liu, Wenlei Xie, Zhiyong DeMartinis, Nicholas Harel, Brian T Braley, Gabriel H Kozak, Rouba Park, Lovingly Gray, David L A Neurofunctional Domains Approach to Evaluate D1/D5 Dopamine Receptor Partial Agonism on Cognition and Motivation in Healthy Volunteers With Low Working Memory Capacity |
title | A Neurofunctional Domains Approach to Evaluate D1/D5 Dopamine Receptor Partial Agonism on Cognition and Motivation in Healthy Volunteers With Low Working Memory Capacity |
title_full | A Neurofunctional Domains Approach to Evaluate D1/D5 Dopamine Receptor Partial Agonism on Cognition and Motivation in Healthy Volunteers With Low Working Memory Capacity |
title_fullStr | A Neurofunctional Domains Approach to Evaluate D1/D5 Dopamine Receptor Partial Agonism on Cognition and Motivation in Healthy Volunteers With Low Working Memory Capacity |
title_full_unstemmed | A Neurofunctional Domains Approach to Evaluate D1/D5 Dopamine Receptor Partial Agonism on Cognition and Motivation in Healthy Volunteers With Low Working Memory Capacity |
title_short | A Neurofunctional Domains Approach to Evaluate D1/D5 Dopamine Receptor Partial Agonism on Cognition and Motivation in Healthy Volunteers With Low Working Memory Capacity |
title_sort | neurofunctional domains approach to evaluate d1/d5 dopamine receptor partial agonism on cognition and motivation in healthy volunteers with low working memory capacity |
topic | Regular Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251631/ https://www.ncbi.nlm.nih.gov/pubmed/32055822 http://dx.doi.org/10.1093/ijnp/pyaa007 |
work_keys_str_mv | AT balicegordonrita aneurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity AT honeygarryd aneurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity AT chathamchristopher aneurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity AT arceestibaliz aneurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity AT duvvurisridhar aneurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity AT naylormelissagraham aneurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity AT liuwenlei aneurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity AT xiezhiyong aneurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity AT demartinisnicholas aneurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity AT harelbriant aneurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity AT braleygabrielh aneurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity AT kozakrouba aneurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity AT parklovingly aneurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity AT graydavidl aneurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity AT balicegordonrita neurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity AT honeygarryd neurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity AT chathamchristopher neurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity AT arceestibaliz neurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity AT duvvurisridhar neurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity AT naylormelissagraham neurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity AT liuwenlei neurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity AT xiezhiyong neurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity AT demartinisnicholas neurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity AT harelbriant neurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity AT braleygabrielh neurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity AT kozakrouba neurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity AT parklovingly neurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity AT graydavidl neurofunctionaldomainsapproachtoevaluated1d5dopaminereceptorpartialagonismoncognitionandmotivationinhealthyvolunteerswithlowworkingmemorycapacity |